T. Matsuoka

发表

EP2 and EP4 receptors on muscularis resident macrophages mediate LPS-induced intestinal dysmotility via iNOS upregulation through cAMP/ERK signals

S. Narumiya, Y. Urade, M. Michishita, 2011, American journal of physiology. Gastrointestinal and liver physiology.

677 IDENTIFICATION OF EP4 AS A POTENTIAL TARGET FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER USING A NOVEL XENOGRAFT MODEL

G. Tsujimoto, Y. Okuno, S. Narumiya, 2010 .

Prostaglandin D2 as a mediator of allergic asthma.

S. Narumiya, Y. Urade, A. Mizoguchi, 2000, Science.

Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1

S. Narumiya, K. Kabashima, T. Matsuoka, 2007, The Journal of experimental medicine.

Facilitation of Th 1-mediated immune response by prostaglandin E receptor EP 1

S. Narumiya, K. Kabashima, T. Matsuoka, 2022 .

Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice.

S. Narumiya, Y. Sugimoto, A. Ichikawa, 1998, Biochemical and biophysical research communications.

Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2).

S. Narumiya, Y. Sugimoto, A. Ichikawa, 1999, Proceedings of the National Academy of Sciences of the United States of America.

The roles of prostanoids in infection and sickness behaviors

S. Narumiya, T. Matsuoka, 2008, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Altered pain perception and inflammatory response in mice lacking prostacyclin receptor

S. Narumiya, Y. Sugimoto, A. Ichikawa, 1997, Nature.

Oral administration of the thrombin receptor antagonist E5555 (atopaxar) attenuates intimal thickening following balloon injury in rats.

I. Hishinuma, T. Matsuoka, H. Kuramochi, 2011, European journal of pharmacology.

Prostaglandin E2–prostoglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation-induced systemic immunosuppression

S. Narumiya, Takao Shimizu, Y. Kita, 2011, Proceedings of the National Academy of Sciences.

Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity.

S. Narumiya, T. Honda, K. Kabashima, 2009, The Journal of allergy and clinical immunology.

Major roles of prostanoid receptors IP and EP(3) in endotoxin-induced enhancement of pain perception.

S. Narumiya, Y. Sugimoto, A. Ichikawa, 2001, Biochemical pharmacology.

Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity

K. Katagiri, T. Kinashi, S. Narumiya, 2003, Nature Immunology.

Major roles of prostanoid receptors IP and EP3 in endotoxin-induced enhancement of pain perception11Abbreviations:, prostaglandin E receptor subtype 1; IP, prostaglandin I receptor; LPS, lipopolysaccharide; and WT, wild-type mice.

S. Narumiya, Y. Sugimoto, A. Ichikawa, 2001 .

The novel and orally active thrombin receptor antagonist E5555 (Atopaxar) inhibits arterial thrombosis without affecting bleeding time in guinea pigs.

I. Hishinuma, T. Matsuoka, H. Kuramochi, 2011, European journal of pharmacology.

The roles of prostanoids in inflammation, allergy, and immunity

S. Narumiya, T. Matsuoka, 2008 .

1102-48 Inhibitory effect of E5555, an orally active thrombin receptor antagonist, on intimal hyperplasia following balloon injury

I. Hishinuma, T. Matsuoka, T. Kawahara, 2004 .

Prostaglandin E2 Suppresses Poly I: C-Stimulated Cytokine Production Via EP2 and EP3 in Immortalized Human Corneal Epithelial Cells

C. Sotozono, S. Kinoshita, T. Matsuoka, 2012, Cornea.

Prostaglandin E2 suppresses polyinosine–polycytidylic acid (polyI:C)-stimulated cytokine production via prostaglandin E2 receptor (EP) 2 and 3 in human conjunctival epithelial cells

S. Kinoshita, N. Yokoi, T. Matsuoka, 2011, British Journal of Ophthalmology.

Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis

S. Narumiya, K. Fukuda, T. Matsuoka, 2010, Proceedings of the National Academy of Sciences.

Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis.

S. Narumiya, S. Kinoshita, T. Matsuoka, 2009, The Journal of allergy and clinical immunology.

Prostaglandin Receptor Signaling in Disease

S. Narumiya, T. Matsuoka, 2007, TheScientificWorldJournal.

The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut.

S. Narumiya, Takuya Kobayashi, K. Kabashima, 2002, The Journal of clinical investigation.

Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3

Atsushi Ichikawa, Yukihiko Sugimoto, Shuh Narumiya, 1998, Nature.

PGE2‐EP2 signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF‐κB

R. Morishita, K. Nozaki, J. Ando, 2011, British journal of pharmacology.

Epistatic interaction between Toll-like receptor 3 (TLR3) and prostaglandin E receptor 3 (PTGER3) genes.

S. Akira, T. Inatomi, C. Sotozono, 2012, The Journal of allergy and clinical immunology.

Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3

S. Narumiya, Y. Sugimoto, A. Ichikawa, 2005, Nature Immunology.

Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model.

Yasushi Okuno, Gozoh Tsujimoto, Shuh Narumiya, 2010, Cancer research.

Prostaglandin E receptor subtype EP3 downregulates TSLP expression in human conjunctival epithelium

S. Kinoshita, N. Yokoi, T. Matsuoka, 2010, British Journal of Ophthalmology.

Prostaglandin E2–EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion

S. Narumiya, Y. Sugimoto, T. Matsuoka, 2009, Nature Medicine.

Role of citron kinase as a target of the small GTPase Rho in cytokinesis

K. Fujisawa, S. Narumiya, H. Bito, 1998, Nature.

A GPR40 agonist GW9508 suppresses CCL5, CCL17, and CXCL10 induction in keratinocytes and attenuates cutaneous immune inflammation.

S. Narumiya, Tomoko Fujita, T. Honda, 2011, The Journal of investigative dermatology.

Thromboxane receptor activation enhances striatal dopamine release, leading to suppression of GABAergic transmission and enhanced sugar intake

A. Nishi, T. Shuto, S. Narumiya, 2011, The European journal of neuroscience.

Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: a randomized phase II, placebo-controlled trial.

S. Narumiya, T. Chiba, N. Oshitani, 2010, Inflammatory bowel diseases.

Prostaglandin F2α receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-β

S. Narumiya, M. Mishima, Takao Shimizu, 2009, Nature Medicine.

Prostaglandin D2 Inhibits the Production of IFN-γ by Invariant NK T Cells: Consequences in the Control of B16 Melanoma1

Christophe Paget, Philippe Gosset, Shuh Narumiya, 2008, The Journal of Immunology.

Prostaglandin E receptor EP1 enhances GABA‐mediated inhibition of dopaminergic neurons in the substantia nigra pars compacta and regulates dopamine level in the dorsal striatum

S. Narumiya, H. Nawa, A. Mizoguchi, 2009, The European journal of neuroscience.

Discovery and development of aryl-fused imidazole-based angiotensin II antagonists

T. Matsuoka, T. Musha, O. Hiroshima, 1994 .

Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP2 (gene targetingyfertilizationyovulationyprostanoidsygonadotropins)

S. Narumiya, Y. Sugimoto, A. Ichikawa, 1999 .

Pharmacology of E4101, a novel, selective and orally active DA-1 dopamine receptor agonist

T. Matsuoka, S. Suda, N. Mori, 1990 .

Retinal nerve fiber layer defect as an early manifestation of diabetic retinopathy.

E. Chihara, T. Matsuoka, Y. Ogura, 1993, Ophthalmology.